PreciseDx is based in New York, NY. It has raised $32M in total funding. Latest round: Series B.
PreciseDx is based in New York, NY. PreciseDx has raised $32M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2024. The round record for PreciseDx runs through 2024; nothing later has been disclosed. Investors on record include Eventide Asset Management, Merck Global Health Innovation Fund, Philips Ventures, Labcorp, Quest Diagnostics, GenHenn Capital Venture. 6 distinct backers are named across the disclosed rounds.
Every PreciseDx figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in New York at a similar stage.
3 disclosed rounds on record, including 2 reported through SEC Form D filings.
SEC Form D filings report the amount sold against a stated offering size, which can differ from press-reported round totals, and they do not name the round — those entries appear as Private financing.
Company funding database · Investor directory · Founder database · Mega-rounds 2026